NEW YORK (Reuters) - Shares of Amgen Inc (AMGN.O) rose 12.7 percent after the closing bell on Tuesday after its Denosumab drug succeeded in a late-stage study of breast cancer patients.
Shares were up at $58.88 after closing on the Nasdaq at $52.23.
© Thomson Reuters 2009 All rights reserved.
Cargo plane crash in China
Safer stoning at Haj
Break dancing robot wipes the floor
Bomb caused Russian train crash
Couple crashes White House dinner
Dozens dead in Russian train crash
Made in China: a new 'electromobile'
Woods home after car crash
Obama-saved turkey does Disneyland
Giant pandas arrive in Australia
uk.reuters.com
Help and Contact Us |
Advertise With Us |
Mobile |
Newsletters |
RSS
|
Interactive TV |
Labs |
Archive |
Site Index |
Video Index
Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers
International Editions: Africa | Arabic | Argentina | Brazil | Canada | China | France | Germany | India | Italy | Japan | Latin America | Mexico | Russia | Spain | United Kingdom | United States
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
